Furthermore, our data indicate that DMF treatment significantly reduces astrogliosis in the PFC and stratum lacunosum-moleculare, possibly by enhancing the expression of anti-inflammatory genes such as SPHK2, providing further evidence of the neuroprotective effect of this compound against TDP-43-dependent FTD. The gene discussed is SPHK2; the disease is frontotemporal dementia.